SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-001252
Filing Date
2021-02-24
Accepted
2021-02-24 07:30:12
Documents
13
Period of Report
2021-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_022321.htm   iXBRL 8-K 24452
2 EXHIBIT 99.1 exh_991.htm EX-99.1 7350
  Complete submission text file 0001171843-21-001252.txt   207195

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cytk-20210222.xsd EX-101.SCH 2732
4 XBRL LABEL FILE cytk-20210222_lab.xml EX-101.LAB 35273
5 XBRL PRESENTATION FILE cytk-20210222_pre.xml EX-101.PRE 23130
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_022321_htm.xml XML 3661
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 21668486
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences